Skip to Late-Breaking Abstracts »
All odd numbered posters will be presented on Friday, November 8, 2019, while even numbered posters will be presented on Saturday, November 9, 2019.
Posters will be on display from 7 a.m. - 8 p.m., with the presenting authors required to be at their posters during lunch (12:30 - 2 p.m. on Friday, Nov. 8, and 12:35 - 2:05 p.m. on Saturday, Nov. 9) and also during the poster reception (6:30 - 8p.m. on Friday, Nov. 8, and 7 - 8:30 p.m. on Saturday, Nov. 9).
# | Title | Authors | Category | Keywords |
---|---|---|---|---|
P272 | SRF231, a fully human high-affinity anti-CD47 antibody, exerts potent preclinical antitumor activity through engagement of the Fc receptor (FcR), CD32a | Marisa Peluso, MS; Kshama Doshi, PhD; Caroline M. Armet, BS; Li Zhang; Rachel W. O'Connor, BS; Matthew P. Rausch, PhD; Jonathan A. Hill, PhD; Benjamin Lee, MD PhD; Pamela Holland, PhD; Vito J. Palombella, PhD; Alison M. Paterson, PhD; | Checkpoint Blockade Therapy | Antibody; Monocyte/Macrophage; Myeloid cells; Targeted therapy |